(19)
(11) EP 4 121 541 A2

(12)

(88) Date of publication A3:
28.10.2021

(43) Date of publication:
25.01.2023 Bulletin 2023/04

(21) Application number: 21772422.8

(22) Date of filing: 12.03.2021
(51) International Patent Classification (IPC): 
C12N 15/70(2006.01)
A61P 31/04(2006.01)
C12N 15/74(2006.01)
A61K 39/05(2006.01)
C07K 14/34(2006.01)
C12P 21/02(2006.01)
(52) Cooperative Patent Classification (CPC):
C12P 21/02; C12P 21/06; C12N 9/0051; C12Y 108/01007; C12Y 108/01008; C12Y 304/11018; C12N 9/485; C12N 15/70; C07K 14/34; C07K 14/33; C07K 14/005; C12N 2710/16222; C07K 14/5428; C07K 14/31
(86) International application number:
PCT/US2021/022126
(87) International publication number:
WO 2021/188379 (23.09.2021 Gazette 2021/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 16.03.2020 US 202016819775
16.03.2020 US 202062990083 P
24.02.2021 US 202163152954 P

(71) Applicant: Fina Biosolutions LLC
Rockville, MD 20850 (US)

(72) Inventors:
  • CHANG, Min-Ju
    Gaithersburg, Maryland 20878 (US)
  • OGANESYAN, Natalia
    Potomac, Maryland 20878 (US)
  • LEES, Andrew
    Silver Spring, Maryland 20910 (US)

(74) Representative: Forresters IP LLP 
Skygarden Erika-Mann-Straße 11
80636 München
80636 München (DE)

   


(54) PRODUCTION OF SOLUBLE RECOMBINANT PROTEIN